1. Canadian Agency for Drugs and Technologies in Health. 2007. Evidence for PPI use in gastroesophageal reflux disease, dyspepsia and peptic ulcer disease: Scientific report. Optimal Therapy Report - COMPUS, pp. 1(2). Available at: http://www.cadth.ca/index.php/en/compus/current-topics/ppis.